• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ROTAWIRE AND WIRECLIP TORQUER; CATHETER, CORONARY, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ROTAWIRE AND WIRECLIP TORQUER; CATHETER, CORONARY, ATHERECTOMY Back to Search Results
Model Number 3520
Device Problem Detachment of Device or Device Component (2907)
Patient Problems Ventricular Fibrillation (2130); Foreign Body In Patient (2687); Thrombosis/Thrombus (4440)
Event Date 03/04/2021
Event Type  Death  
Event Description
It was reported that the tip of the guidewire detached, and patient death occurred.A 330cm rotawire and wireclip torquer was selected for use in an atherectomy procedure in the ostial right coronary artery (rca) to treat angina pectoris.A bypass was used to retrograde the seg.1 of the rca.After ablation was successfully performed, the rotawire was withdrawn.Upon removal, it was discovered that the 2.2cm radiopaque tip of the guidewire remained in the proximal portion of the vessel.A stent was implanted to push the device fragment into the vessel wall.Thrombus formation occurred, and the patient went into ventricular fibrillation.Cardiac massage was performed, and the patient was ventilated and transferred to the intensive care unit.The patient died on (b)(6) 2021.
 
Event Description
It was reported that the tip of the guidewire detached, and patient death occurred.A 330cm rotawire and wireclip torquer was selected for use in an atherectomy procedure in the ostial right coronary artery (rca) to treat angina pectoris.A bypass was used to retrograde the seg.1 of the rca.After ablation was successfully performed, the rotawire was withdrawn.Upon removal, it was discovered that the 2.2cm radiopaque tip of the guidewire remained in the proximal portion of the vessel.A stent was implanted to push the device fragment into the vessel wall.Thrombus formation occurred, and the patient went into ventricular fibrillation.Cardiac massage was performed, and the patient was ventilated and transferred to the intensive care unit.The patient died on (b)(6) 2021.It was further reported that thrombus formation started before the stent was implanted.An attempt was made to snare the device fragment.At this time, occlusion of the vessel occurred, and the thrombus formation progressed to the distal portion of the vessel.Under cpr, another complication occurred.The patient experienced a liver partial tear and went to emergency surgery.Using a non-boston scientific heart pump and extracorporeal membrane oxygenation (ecmo), the patient was stabilized.Then the patient experienced acute respiratory distress syndrome (ards) and needed lung ventilation support, but the next of kin did not want that.The physician is of the opinion that the rotawire was related to patient death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROTAWIRE AND WIRECLIP TORQUER
Type of Device
CATHETER, CORONARY, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11529498
MDR Text Key241057645
Report Number2134265-2021-03587
Device Sequence Number1
Product Code MCX
UDI-Device Identifier08714729185871
UDI-Public08714729185871
Combination Product (y/n)N
PMA/PMN Number
P900056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 03/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/19/2022
Device Model Number3520
Device Catalogue Number3520
Device Lot Number0026212852
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/15/2021
Initial Date FDA Received03/19/2021
Supplement Dates Manufacturer Received03/19/2021
Supplement Dates FDA Received03/22/2021
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Required Intervention;
-
-